Get started

PersonGen (China)

Homepage: persongen.com
ROR: 03a5tyh47
OpenAlex ID: I4210129654
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
2018 · Xiaowen Tang, Lin Yang, et al. · PubMed · 406
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
2016 · Fengtao You, Licui Jiang, et al. · Science China Life Sciences · 151
PDF
A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.
2019 · Fengtao You, Yinyan Wang, et al. · PubMed · 127
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
2022 · Mingzhi Zhang, Dan Chen, et al. · Clinical Cancer Research · 115
PDF
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
2017 · Ying Chen, Fengtao You, et al. · Oncotarget · 51
PDF
The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration
2012 · Xingding Zhang, Yu Jing, et al. · The International Journal of Biochemistry & Cell Biology · 47
PDF
Effects of Csf1R-Targeted Chimeric Antigen Receptor-Modified Nk92Mi & T Cells on Tumor-Associated Macrophages
2018 · Ping Zhang, Songbo Zhao, et al. · Immunotherapy · 43
La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease
2018 · Huimin Meng, Xue Sun, et al. · Clinical Immunology · 42
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
2022 · Xuanqi Cao, Haiping Dai, et al. · Experimental Hematology and Oncology · 39
PDF
Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma
2022 · Hai-ping Dai, Wei Cui, et al. · Biomarker Research · 32
PDF
Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization
2016 · Dan Chen, Jianxuan Zou, et al. · Immunopharmacology and Immunotoxicology · 29
MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.
2021 · Xiaochen Zhai, Fengtao You, et al. · PubMed · 27
Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models
2023 · Tian Wang, Kailu Zhang, et al. · Life Sciences · 22
B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors
2024 · Licui Jiang, Fengtao You, et al. · Cancer Research · 21
Abstract A014: Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy
2019 · Qiao Li, Yi Wang, et al. · Cancer Immunology Research · 21
A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma
2021 · Mingzhi Zhang, Xiaorui Fu, et al. · Blood · 20
Nanobody-based anti-CD22-chimeric antigen receptor T cell immunotherapy exhibits improved remission against B-cell acute lymphoblastic leukemia
2022 · Tingting Zhang, Tian Wang, et al. · Transplant Immunology · 19
PDF
First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.
2020 · Mingzhi Zhang, Lin Yang, et al. · Journal of Clinical Oncology · 19
Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature
2021 · Ying Qian, Zijun Qian, et al. · Frontiers in Medicine · 16
PDF
CD7 protein plays a crucial role in T cell infiltration in tumors
2023 · Binjie Sheng, Kailu Zhang, et al. · Heliyon · 13
PDF
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
2023 · Shuangshuang Fan, Tian Wang, et al. · European journal of medical research · 12
PDF
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignancies.
2021 · Dan Chen, Fengtao You, et al. · PubMed · 11
Enhanced efficacy of CD19 / CD22 bispecific CAR‐T cells with EAAAK linker on B‐cell malignancies
2023 · Renyuxue Ma, Fengtao You, et al. · European Journal Of Haematology · 10
The research significance of concomitant use of CAR-CD138-NK and CAR-CD19-NK to target multiple myelomas
2018 · Songbo Zhao, Zhichao Han, et al. · European Journal of Inflammation · 10
Correlation enhanced modularity-based belief propagation method for community detection in networks
2016 · Darong Lai, Xin Shu, et al. · Journal of Statistical Mechanics Theory and Experiment · 8
PDF
Works count: 48
Citation count: 5,799
Year
Topic
Type